Form D · Biotechnology
Adverum Biotechnologies, Inc.
Redwood City, CA · CIK 0001501756
Offering snapshot reported Feb 21, 2024 · SEC filing
- Reported sold
- $128M Offering amount: $128M
- Investors reported
- 20 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 7, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 21, 2024 | Initial | $127,800,000 | No comparison | 20 | SEC filing |
| Sep 8, 2014 | Initial | $9,999,995 | No comparison | 1 | SEC filing |
| Apr 28, 2014 | Initial | $55,127,152 | No comparison | 45 | SEC filing |
| Nov 26, 2013 | Initial | $5,653,890 | No comparison | 16 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $7.65M
- Finders' fees
- $0
- Form D file number
- 021-505765
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Cowen and Company, LLC | 7616 | |
| Truist Securities, Inc. | 6271 |
Source: Form D, filed Feb 21, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Linda Bain | Executive |
| Mark Blumenkranz | Director |
| Thomas Chalberg | Director, Executive |
| Laurent Fischer | Director, Executive |
| Mehdi Gasmi | Executive |
| Soo Hong | Director |
| Hans Hull | Executive |
| Mark Lupher | Director |
| Patrick Machado | Director |
| John Mc Laughlin | Director |
| C. David Nicholson | Director |
| Rabia Gurses Ozden | Director |
| Linda Rubinstein | Executive |
| Steven Schwartz | Director |
| Steven D. Schwarz | Director |
| James Scopa | Director |
| Setareh Seyedkazemi | Executive |
| Kishor Peter Soparkar | Executive |
| Dawn Svoronos | Director |
| Reed Tuckson | Director |
| Paul Wachter | Director |
| Scott Whitcup | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
100 Cardinal Way
Redwood City, CA, 94063
Redwood City, CA, 94063